Lon­za en­ters the ex­o­some ther­a­py space with ac­qui­si­tion of still-new Co­di­ak site

In an­tic­i­pa­tion of tack­ling the man­u­fac­tur­ing prob­lems that come with ex­o­some ther­a­peu­tics head on, Co­di­ak Bio­Sciences built a 12,000-square-foot man­u­fac­tur­ing site …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER